Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05924477Not ApplicableRecruiting
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Glaucoma
StudychairStart date: 2023-07-11
NCT04750655Phase 4Completed
Antibiotic Resistance In Eye Surgeries
Antibiotic ResistanceGut ResistomeOcular Surface Microbiome
PrincipalinvestigatorStart date: 2021-03-01
NCT02805257Phase 2Completed
Ahmed Glaucoma Valve Surgery With Mitomycin-C
GlaucomaNeovascular GlaucomaPrimary Open Angle Glaucoma+1 more
PrincipalinvestigatorStart date: 2016-06-01

Research Network

Collaboration Network

10 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thuy Doan, MD, PhD

University of California, San Francisco

Moderately Similar
4 trials

Shared therapeutic areas:

Antibiotic Resistance, MicrobialGut ResistomeOcular Surface Microbiome

Worked with same sponsors:

Stanford UniversityUniversity of California, San Francisco
Collaborated on 1 trial
Similarity Score34%

Jennifer Rose-Nussbaumer, MD

Stanford University

Related
7 trials

Shared therapeutic areas:

Glaucoma

Worked with same sponsors:

National Eye Institute (NEI)Stanford University+2 more
Collaborated on 1 trial
Similarity Score14%

Thuy Doan, MD, PhD

University of California San Fransicso

Related
1 trials

Shared therapeutic areas:

Glaucoma

Worked with same sponsors:

National Eye Institute (NEI)Stanford University+2 more
Collaborated on 1 trial
Similarity Score14%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Glaucoma, Primary Open AngleGlaucoma
Similarity Score9%

Jeff Wells, PharmD, MBA

Glaukos Corporation

Related
5 trials

Shared therapeutic areas:

GlaucomaGlaucoma, Primary Open Angle
Similarity Score9%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

GlaucomaGlaucoma, Primary Open Angle
Similarity Score9%

Jeffrey L Goldberg, MD PhD

Stanford University

Related
5 trials

Shared therapeutic areas:

GlaucomaGlaucoma, Primary Open Angle

Worked with same sponsors:

Stanford University
Similarity Score9%

Kerry Stephens, O.D.

Glaukos Corporation

Related
5 trials

Shared therapeutic areas:

Glaucoma, Primary Open AngleGlaucoma
Similarity Score9%

Ingeborg Stalmans, MD, Phd

Universitaire Ziekenhuizen KU Leuven

Related
5 trials

Shared therapeutic areas:

GlaucomaGlaucoma, Primary Open Angle
Similarity Score9%

Leopoldo Baiza Durán, MD

Laboratorios Sophia S.A de C.V.

Related
12 trials

Shared therapeutic areas:

GlaucomaGlaucoma, Primary Open Angle
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05924477Not ApplicableStudyChair

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Glaucoma
Recruiting
NCT04750655Phase 4PrincipalInvestigator

Antibiotic Resistance In Eye Surgeries

Antibiotic ResistanceGut ResistomeOcular Surface Microbiome
Completed
NCT02805257Phase 2PrincipalInvestigator

Ahmed Glaucoma Valve Surgery With Mitomycin-C

GlaucomaNeovascular GlaucomaPrimary Open Angle Glaucoma+1 more
Completed

All 3 trials loaded